Article Details
Retrieved on: 2022-09-26 08:37:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sydney, Australia, September 23, 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here